Exchange: NYSE·Updated 07:30 PM EDT
News
all
press releases
Is Zimmer Biomet Stock Worth Retaining in Your Portfolio Now?
ZBH's growth outlook is backed by healthy procedure demand and Z1, HAMMR and OrthoGrid adoption, though debt and competition remain concerns.
Zacks
More News
Is ISRG's Software Strategy Becoming as Important as Its Robots?
ISRG's software roadmap is strengthening da Vinci 5, with new features, renewals and recurring service revenues reinforcing its digital ecosystem.
Zacks
SYK Stock Gains 3.8% Since March-End: What's Driving the Uptrend?
Stryker has gained 3.8% since March-end as Mako robotics, hospital capital demand and international growth drive momentum.
Zacks
Is SYK Worth Buying as Growth Improves but Execution Risks Persist?
Stryker's stronger growth, margin gains and product pipeline support the case, but cyber costs, supply constraints and acquisition execution keep risks elevated.
Zacks
Can Stryker's Q2 Recovery and Guidance Support a Stronger Second Half?
Stryker enters the second half with Q2 momentum restored, but meeting guidance hinges on production, backlog conversion and managing cyber and supply risks.
Zacks
Stryker Up 13.6% in 3 Months as Recovery Gains Strength, What's Next?
Stryker's 13.6% three-month rally reflects stronger sales, margins and production, but execution risks and a premium peer valuation could test further gains.
Zacks
Here's Why Zimmer Biomet (ZBH) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
Boston Scientific's 2026 Guidance Cut Puts Its Recovery to the Test
Boston Scientific's 2026 guidance cut tests its recovery as WATCHMAN weakness, EP share losses and delayed margin gains push a broader rebound toward 2028.
Zacks
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
ZBH's Q2 Earnings Beat, '26 View Raised, Stock Up in Pre-Market
ZBH beats second-quarter earnings and revenue estimates, raises its 2026 outlook and gains in pre-market despite pressure on adjusted margins.
Zacks

Advertisement|Remove ads.